CAMBELL INTERNATIONAL HOLDING CORP.: M&A transaction — Bitmis completes reverse merger with Cambell International, shifts focus to β-carotene health products

CAMBELL INTERNATIONAL HOLDING CORP.

Reverse acquisition of Cambell International closed on Dec 30, 2022; Bitmis issued 1M common shares and transferred 9M Series A Preferred shares to Cambell shareholders.
Xiaoyan Yuan resigned as CEO/CFO/COO/director; Sun Xiuzhi appointed as CEO, CFO, and director effective immediately.
Post-merger, company will focus on natural β-carotene extraction and health food products via LiaoNing KangBaiEr Biotechnology Development Co., Ltd.
Bitmis trades on OTC Expert Market under ticker BIMT; no financial statements provided yet.

item 1.01 item 2.01 item 3.02 item 5.01 item 5.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

CAMBELL INTERNATIONAL HOLDING CORP. underwent a change of control involving Cambell International Holding Limited (closed 2022-12-30).

Action: change of control
Counterparty: Cambell International Holding Limited
Closing: 2022-12-30

Exact text from the filing

Pursuant to the Business Combination, a change of control of Bitmis Corp. occurred as of the Closing Date.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

CAMBELL INTERNATIONAL HOLDING CORP. completed an acquisition involving Cambell International Holding Limited and its shareholders for aggregate of 1,000,000 shares of our common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stoc (closed 2022-12-30).

Action: acquisition
Counterparty: Cambell International Holding Limited and its shareholders
Consideration: aggregate of 1,000,000 shares of our common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stoc
Closing: 2022-12-30

Exact text from the filing

Shareholders”) to acquire all the issued and outstanding capital stock of Cambell International in exchange for the issuance to the Cambell Shareholders of an aggregate of 1,000,000 shares (the “Shares”) of our common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stock owned by her

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001213900-22-084079

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.